Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
David B Rein
Affiliation
NORC at the University of Chicago
ORCID
Career Start Year
1999
Papers
75
H Index
27
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37389780
A Mixed-Methods Approach for Evaluating Implementation Processes and Program Costs for a Hypertension Management Program Implemented in a Federally Qualified Health Center.
Prev Sci
2024
36637915
Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years.
Diabetes Care
2023
37022712
Association Between Social Determinants of Health and Examination-Based Vision Loss vs Self-reported Vision Measures.
JAMA Ophthalmol
2023
37318810
Prevalence of Diabetic Retinopathy in the US in 2021.
JAMA Ophthalmol
2023
37387725
Effectiveness evaluation of a hypertension management program in a Federally Qualified Health Center (FQHC).
Prev Med Rep
2023
37140901
Validity of Administrative Claims and Electronic Health Registry Data From a Single Practice for Eye Health Surveillance.
JAMA Ophthalmol
2023
34560128
The Economic Burden of Vision Loss and Blindness in the United States.
Ophthalmology
2022
35797011
County-Level Variation in the Prevalence of Visual Acuity Loss or Blindness in the US.
JAMA Ophthalmol
2022
36178388
Evaluating Evidence-Informed Behavioral Health Models to Improve HIV Health Outcomes: Quantitative Findings from the Ryan White HIV/AIDS Program Special Projects of National Significance Black Men Who Have Sex with Men Initiative.
AIDS Patient Care STDS
2022
36326752
Prevalence of Age-Related Macular Degeneration in the US in 2019.
JAMA Ophthalmol
2022
35240921
High-Risk Injection-Related Practices Associated with anti-HCV Positivity among Young Adults Seeking Services in Three Small Cities in Wisconsin.
Subst Use Misuse
2022
35238912
Trends in Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Medicare Part B Fee-for-Service Beneficiaries.
JAMA Ophthalmol
2022
32663529
Vision Impairment and Blindness Prevalence in the United States: Variability of Vision Health Responses across Multiple National Surveys.
Ophthalmology
2021
34530688
The Prevalence of Diagnosis of Major Eye Diseases and their Associated Payments in the Medicare Fee-for-Service Program.
Ophthalmic Epidemiol
2021
33983373
Prevalence of Visual Acuity Loss or Blindness in the US: A Bayesian Meta-analysis.
JAMA Ophthalmol
2021
31505088
Defining the hepatitis C cure cascade in an Urban health system using the electronic health record.
J Viral Hepat
2020
28941361
Hepatitis C virus testing for case identification in persons born during 1945-1965: Results from three randomized controlled trials.
Hepatology
2018
30222920
Hepatitis C care cascade among persons born 1945-1965: 3 medical centers.
Am J Manag Care
2018
29566863
Establishing a Vision and Eye Health Surveillance System for the Nation: A Status Update on the Vision and Eye Health Surveillance System.
Ophthalmology
2018
27496859
Implementation of Birth-Cohort Testing for Hepatitis C Virus.
Health Promot Pract
2017
28358948
Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System.
JAMA Ophthalmol
2017
28288075
An Electronic Health Record-based Intervention to Promote Hepatitis C Virus Testing Among Adults Born Between 1945 and 1965: A Cluster-randomized Trial.
Med Care
2017
29404448
Potential epidemiologic, economic, and budgetary impacts of current rates of hepatitis C treatment in medicare and non-medicare populations.
Hepatol Commun
2017
28796854
The Promise and Potential of Pediatric Vision Data.
JAMA Ophthalmol
2017
27770543
Uptake of hepatitis C screening, characteristics of patients tested, and intervention costs in the BEST-C study.
Hepatology
2017
26707033
The burden of hepatitis C to the United States Medicare system in 2009: Descriptive and economic characteristics.
Hepatology
2016
27394647
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.
Lancet
2016
27317459
Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children.
Vaccine
2016
24776636
Hepatitis C virus testing perspectives among primary care physicians in four large primary care settings.
Health Promot Pract
2015
26261202
Reply to Messori.
Clin Infect Dis
2015
26091742
Nepali earthquakes and the risk of an epidemic of hepatitis E.
Lancet
2015
25896194
HIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary Care.
Am J Prev Med
2015
25778747
The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus.
Clin Infect Dis
2015
25595745
Hepatitis C virus antibody positivity and predictors among previously undiagnosed adult primary care outpatients: cross-sectional analysis of a multisite retrospective cohort study.
Clin Infect Dis
2015
23511113
Attributes associated with eye care use in the United States: a meta-analysis.
Ophthalmology
2013
24335062
Vision problems are a leading source of modifiable health expenditures.
Invest Ophthalmol Vis Sci
2013
21877675
The potential cost-effectiveness of amblyopia screening programs.
J Pediatr Ophthalmol Strabismus
2012
23754160
The economics of the initial preventive physical examination in medicare-reply.
Arch Ophthalmol
2012
23245608
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lancet
2012
23245607
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lancet
2012
23245604
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lancet
2012
22922026
Data to guide the "test and treat era" of hepatitis C.
Gastroenterology
2012
22895429
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
MMWR Recomm Rep
2012
22232367
The cost-effectiveness of Welcome to Medicare visual acuity screening and a possible alternative welcome to medicare eye evaluation among persons without diagnosed diabetes mellitus.
Arch Ophthalmol
2012
22056542
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.
Ann Intern Med
2012
22121109
The global burden of hepatitis E virus genotypes 1 and 2 in 2005.
Hepatology
2012
20739252
Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States.
Dig Liver Dis
2011
21800750
Models of community-based hepatitis B surface antigen screening programs in the U.S. and their estimated outcomes and costs.
Public Health Rep
2011
21492158
The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.
Health Serv Res
2011
21076360
Cost-effectiveness of glaucoma interventions in Barbados and Ghana.
Optom Vis Sci
2011
1 - 50 of 75
Column Actions
Search
Recommended Authors
Yelena Malyuta
Rhode Island Public Health Institute
Career Start Year
2018
Number of shared co-authors
0
Xinkai Zhou
University of California Los Angeles
Career Start Year
2017
Number of shared co-authors
0
Nathaniel Hendrix
Harvard T.H. Chan School of Public Health
Career Start Year
2017
Number of shared co-authors
0
Ailin Song
Duke University Medical Center
Career Start Year
2014
Number of shared co-authors
0
Lucy D'Agostino McGowan
Wake Forest University
Career Start Year
2013
Number of shared co-authors
0
Sitaram Vangala
University of California los angeles
Career Start Year
2013
Number of shared co-authors
0
Charitha Gowda
Nationwide Children's Hospital Columbus
Career Start Year
2012
Number of shared co-authors
0
Craig W Newcomb
University of Pennsylvania Perelman School of Medicine
Career Start Year
2007
Number of shared co-authors
0
Mihail Samnaliev
Axtria Inc.
Career Start Year
2005
Number of shared co-authors
1
Seth A Seabury
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Career Start Year
2005
Number of shared co-authors
0
Goundappa K Balasubramani
University of Pittsburgh School of Public Health
Career Start Year
2004
Number of shared co-authors
0
Dustin D French
Jr. VA Hospital
Career Start Year
2004
Number of shared co-authors
0
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year
2004
Number of shared co-authors
0
Al Ozonoff
Harvard Medical School
Career Start Year
2004
Number of shared co-authors
1
Qingxia Chen
Vanderbilt University Medical Center
Career Start Year
2002
Number of shared co-authors
0
Lawrence E Barker
Centers for Disease Control and Prevention
Career Start Year
2000
Number of shared co-authors
4
Sanjay Basu
The Pirbright Institute
Career Start Year
2000
Number of shared co-authors
14
Sundar S Shrestha
Centers for Disease Control and Prevention
Career Start Year
1999
Number of shared co-authors
3
Alex R Kemper
Nationwide Children's Hospital
Career Start Year
1998
Number of shared co-authors
4
Chi-Hong Tseng
David Geffen School of Medicine, University of California los angeles
Career Start Year
1998
Number of shared co-authors
0
Andrew J Epstein
University of California san francisco
Career Start Year
1993
Number of shared co-authors
0
Dana P Goldman
University of Southern California
Career Start Year
1992
Number of shared co-authors
0
Ari Paltiel
Yale School of Public Health
Career Start Year
1991
Number of shared co-authors
0
Rachel Gold
Kaiser Permanente Center for Health Research, Kaiser Permanente
Career Start Year
1990
Number of shared co-authors
0
Mark S Roberts
School of Public Health, University of Pittsburgh
Career Start Year
1988
Number of shared co-authors
0
John B Wong
Tufts University School of Medicine
Career Start Year
1986
Number of shared co-authors
0
Theodore G Ganiats
university of california san diego
Career Start Year
1983
Number of shared co-authors
0
Scott D Grosse
Centers for Disease Control and Prevention
Career Start Year
1982
Number of shared co-authors
0
Carol M Mangione
Fielding School of Public Health, University of California los angeles
Career Start Year
1981
Number of shared co-authors
3
Sowmya R Rao
Boston University
Career Start Year
1978
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
John S Wittenborn
NORC at the University of Chicago
Co-authored papers
30
Jinan B Saaddine
US Centers for Disease Control and Prevention
Co-authored papers
19
Elizabeth A Lundeen
Centers for Disease Control and Prevention
Co-authored papers
11
Abraham D Flaxman
Institute for Health Metrics and Evaluation, University of Washington
Co-authored papers
8
Km Venkat Narayan
Rollins School of Public Health, Emory University
Co-authored papers
5
Xinzhi Zhang
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers
4
Andrew G Lee
Center for Space Medicine, Baylor College of Medicine
Co-authored papers
4
Steven E Lipshultz
University at Buffalo Jacobs School of Medicine and Biomedical Sciences
Co-authored papers
3
George A Mensah
and Blood Institute
Co-authored papers
3
Ronald Klein
University of Wisconsin School of Medicine and Public Health
Co-authored papers
3
Frederick P Rivara
University of Washington.
Co-authored papers
3
Herbert C Duber
University of Washington School of Medicine
Co-authored papers
3
Derrick A Bennett
Co-authored papers
3
James E Harrison
College of Medicine and Public Health, Flinders University
Co-authored papers
3
Traci E Clemons
The EMMES Corporation
Co-authored papers
3
Emelia J Benjamin
Co-authored papers
3
Zhi-Jie Zheng
Peking University School of Public Health
Co-authored papers
3
Hugh R Taylor
The University of Melbourne
Co-authored papers
3
Jeffrey A Towbin
University of Tennessee Health Science Center
Co-authored papers
3
Saad B Omer
Yale School of Public Health
Co-authored papers
3
Steven D Colan
Boston Children's Hospital, Harvard Medical School
Co-authored papers
3
Charles E Canter
University of Washington
Co-authored papers
2
Anita Patel
Centers for Disease Control and Prevention
Co-authored papers
2
Philip B Mitchell
University of New South Wales
Co-authored papers
2
Aaron Lee
Harvard University, Moorfields Eye Hospital NHS Foundation Trust, St. John's Mercy Hospital, University of British Columbia, University of Washington, Washington University in Saint Louis
Co-authored papers
2
Monica S Vavilala
University of Washington
Co-authored papers
2
Brittany Campbell
Co-authored papers
2
Joseph Kannry
Icahn School of Medicine at Mount Sinai
Co-authored papers
2
Robert G Nelson
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers
2
Jasvinder A Singh
University of Alabama at Birmingham
Co-authored papers
2
1 - 30